AJP - Lung Columbus Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol (March 7, 2003). doi:10.1152/ajplung.00311.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/1/L258    most recent
00311.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (53)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schaphorst, K. L.
Right arrow Articles by Garcia, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaphorst, K. L.
Right arrow Articles by Garcia, J. G.
Submitted on September 13, 2002
Accepted on January 30, 2003

Role of Sphingosine-1 Phosphate in the Enhancement of Endothelial Barrier Integrity by Platelet-Released Products

Kane L. Schaphorst1*, Eddie Chiang1, Keri N. Jacobs1, Ari Zaiman1, Viswanathan Natarajan1, Frederick Wigley1, and Joe G. Garcia1

1 Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA

* To whom correspondence should be addressed. E-mail: kschap{at}jhmi.edu.

In vitro and in vivo evidence indicates that circulating platelets affect both vascular integrity and hemostasis. How platelets enhance the permeability barrier of the vascular endothelium is not well understood. We measured the effect of isolated human platelets on human pulmonary artery endothelial cell (EC) barrier integrity by monitoring transmonolayer electrical resistance. EC barrier function was significantly increased by the addition of platelets(~40% maximum, 2.5 x 106 platelets/ml). Platelet supernatants, derived from 2.5 x 106 platelets/ml, reproduced the barrier enhancement and reversed the barrier dysfunction produced by the edemagenic agonist thrombin, implicating a soluble barrier-promoting factor. The barrier-enhancing effect of platelet supernatants was heat stable, but attenuated by either charcoal delipidation (suggesting a vasoactive lipid mediator) or pertussis toxin, implying involvement of a Gi{alpha}-coupled receptor signal transduction pathway. Sphingosine-1-phosphate (Sph 1-P), a sphingolipid released from activated platelets, is known to ligate G-protein-coupled Edg(endothelial cell differentiation gene) receptors, increase EC electrical resistance, and reorganize the actin cytoskeleton (J Clin Invest 2001; 108:689-701). Infection of EC with an adenoviral vector expressing an antisense oligonucleotide directed against Edg-1, but not infection with control vector, attenuated the barrier-enhancing effect of both platelet supernatants and Sph 1-P. These results indicate that a major physiologically relevant vascular barrier-protective mediator produced by human platelets is sphingosine-1-phosphate.




This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
B. Ho-Tin-Noe, C. Carbo, M. Demers, S. M. Cifuni, T. Goerge, and D. D. Wagner
Innate Immune Cells Induce Hemorrhage in Tumors during Thrombocytopenia
Am. J. Pathol., October 1, 2009; 175(4): 1699 - 1708.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Ho-Tin-Noe, T. Goerge, and D. D. Wagner
Platelets: Guardians of Tumor Vasculature
Cancer Res., July 15, 2009; 69(14): 5623 - 5626.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
C. K. Means and J. H. Brown
Sphingosine-1-phosphate receptor signalling in the heart
Cardiovasc Res, May 1, 2009; 82(2): 193 - 200.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
M. Tauseef, V. Kini, N. Knezevic, M. Brannan, R. Ramchandaran, H. Fyrst, J. Saba, S. M. Vogel, A. B. Malik, and D. Mehta
Activation of Sphingosine Kinase-1 Reverses the Increase in Lung Vascular Permeability Through Sphingosine-1-Phosphate Receptor Signaling in Endothelial Cells
Circ. Res., November 7, 2008; 103(10): 1164 - 1172.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Ho-Tin-Noe, T. Goerge, S. M. Cifuni, D. Duerschmied, and D. D. Wagner
Platelet Granule Secretion Continuously Prevents Intratumor Hemorrhage
Cancer Res., August 15, 2008; 68(16): 6851 - 6858.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
I. N. Gavrilovskaya, E. E. Gorbunova, N. A. Mackow, and E. R. Mackow
Hantaviruses Direct Endothelial Cell Permeability by Sensitizing Cells to the Vascular Permeability Factor VEGF, while Angiopoietin 1 and Sphingosine 1-Phosphate Inhibit Hantavirus-Directed Permeability
J. Virol., June 15, 2008; 82(12): 5797 - 5806.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Goerge, B. Ho-Tin-Noe, C. Carbo, C. Benarafa, E. Remold-O'Donnell, B.-Q. Zhao, S. M. Cifuni, and D. D. Wagner
Inflammation induces hemorrhage in thrombocytopenia
Blood, May 15, 2008; 111(10): 4958 - 4964.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
V. Solodushko, J. C. Parker, and B. Fouty
Pulmonary Microvascular Endothelial Cells Form a Tighter Monolayer when Grown in Chronic Hypoxia
Am. J. Respir. Cell Mol. Biol., April 1, 2008; 38(4): 491 - 497.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
Y. A. Komarova, D. Mehta, and A. B. Malik
Dual Regulation of Endothelial Junctional Permeability
Sci. Signal., November 13, 2007; 2007(412): re8 - re8.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
K. M. Argraves and W. S. Argraves
HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects
J. Lipid Res., November 1, 2007; 48(11): 2325 - 2333.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
M. Xu, C. L. Waters, C. Hu, R. B. Wysolmerski, P. A. Vincent, and F. L. Minnear
Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase
Am J Physiol Cell Physiol, October 1, 2007; 293(4): C1309 - C1318.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
T. H. Westhoff, S. Schmidt, P. Glander, L. Liefeld, S. Martini, G. Offermann, H. H. Neumayer, W. Zidek, M. van der Giet, and K. Budde
The impact of FTY720 (fingolimod) on vasodilatory function and arterial elasticity in renal transplant patients
Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2354 - 2358.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
P. A. Singleton, L. Moreno-Vinasco, S. Sammani, S. L. Wanderling, J. Moss, and J. G. N. Garcia
Attenuation of Vascular Permeability by Methylnaltrexone: Role of mOP-R and S1P3 Transactivation
Am. J. Respir. Cell Mol. Biol., August 1, 2007; 37(2): 222 - 231.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G. Theilmeier, C. Schmidt, J. Herrmann, P. Keul, M. Schafers, I. Herrgott, J. Mersmann, J. Larmann, S. Hermann, J. Stypmann, et al.
High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P3 Lysophospholipid Receptor
Circulation, September 26, 2006; 114(13): 1403 - 1409.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
D. Mehta and A. B. Malik
Signaling Mechanisms Regulating Endothelial Permeability
Physiol Rev, January 1, 2006; 86(1): 279 - 367.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. H. Finigan, S. M. Dudek, P. A. Singleton, E. T. Chiang, J. R. Jacobson, S. M. Camp, S. Q. Ye, and J. G. N. Garcia
Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement: ROLE OF SPHINGOSINE 1-PHOSPHATE RECEPTOR TRANSACTIVATION
J. Biol. Chem., April 29, 2005; 280(17): 17286 - 17293.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
M. Tolle, B. Levkau, P. Keul, V. Brinkmann, G. Giebing, G. Schonfelder, M. Schafers, K. v. W. Lipinski, J. Jankowski, V. Jankowski, et al.
Immunomodulator FTY720 Induces eNOS-Dependent Arterial Vasodilatation via the Lysophospholipid Receptor S1P3
Circ. Res., April 29, 2005; 96(8): 913 - 920.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Feistritzer and M. Riewald
Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation
Blood, April 15, 2005; 105(8): 3178 - 3184.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
K. Kawkitinarong, L. Linz-McGillem, K. G. Birukov, and J. G. N. Garcia
Differential Regulation of Human Lung Epithelial and Endothelial Barrier Function by Thrombin
Am. J. Respir. Cell Mol. Biol., November 1, 2004; 31(5): 517 - 527.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
B. J. McVerry, X. Peng, P. M. Hassoun, S. Sammani, B. A. Simon, and J. G. N. Garcia
Sphingosine 1-Phosphate Reduces Vascular Leak in Murine and Canine Models of Acute Lung Injury
Am. J. Respir. Crit. Care Med., November 1, 2004; 170(9): 987 - 993.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
J.-H. Paik, A. Skoura, S.-S. Chae, A. E. Cowan, D. K. Han, R. L. Proia, and T. Hla
Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization
Genes & Dev., October 1, 2004; 18(19): 2392 - 2403.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
X. Peng, P. M. Hassoun, S. Sammani, B. J. McVerry, M. J. Burne, H. Rabb, D. Pearse, R. M. Tuder, and J. G. N. Garcia
Protective Effects of Sphingosine 1-Phosphate in Murine Endotoxin-induced Inflammatory Lung Injury
Am. J. Respir. Crit. Care Med., June 1, 2004; 169(11): 1245 - 1251.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.